معرفی
Dr. Joanne Arnold is a Senior Lecturer at Chester Medical School within the Faculty of Health, Medicine and Society at the University of Chester. She serves as Programme Leader for the MRes Medical Science program, bringing over a decade of biopharmaceutical industry experience to her academic role. Dr. Arnold's career bridges academic research and therapeutic development, with particular expertise in antibody discovery and protein engineering.
Her educational background includes a PhD in Analytical Science from Dublin City University (2000-2005) and a BSc in Analytical Science from the same institution (1996-2000). Before joining academia, she accumulated extensive industry experience at leading biopharmaceutical companies including AstraZeneca (2005-2025), where she progressed from Scientist II to Senior Research Scientist, and LifeArc (2012-2014) where she served as BioTherapeutics Team Leader.
Dr. Arnold's research focuses on developing therapeutic antibodies for neurological and inflammatory conditions. Her work spans migraine pathophysiology (targeting PAR2 and CGRP pathways), inflammation (C5a and IL-16 targets), and innovative animal models like Xenopus laevis. She has made significant contributions to understanding antibody self-association, structural optimization, and functional characterization. Her recent 2024 publication on double ovulation protocols demonstrates her commitment to refining animal research practices through the 3Rs principle.
Her publication record shows consistent productivity with articles in high-impact journals including PLoS ONE, Cephalalgia, mAbs, and Journal of Biological Chemistry. Her work demonstrates strong translational potential, moving from basic structural insights to therapeutic applications. Dr. Arnold's research has been referenced in numerous patents and has garnered significant attention in the scientific community, with several publications accumulating hundreds of citations.
- Senior Lecturer at University of Chester (2025-present)
- Researcher at University of Chester (2021-2023)
- Programme Leader for MRes Medical Science
- Extensive industry experience in antibody therapeutics development
Dr. Arnold's advising approach likely emphasizes the translation of basic research into therapeutic applications, drawing on her unique industry-academic perspective. Her students would benefit from her expertise in antibody engineering, structural biology, and preclinical development pathways. Her current research continues to focus on optimizing therapeutic antibodies while developing innovative approaches to disease modeling and treatment.
